The existence of Adderall B974 – a controlled treatment at 30mg – presents unique challenges within Oz. While not officially licensed for distribution by the Pharmaceutical Goods Administration, anecdotal indications suggest its introduction via unofficial means. This limited presence fuels concerns regarding well-being, potential abuse, and th